Could removing excess brain iron slow down ALS?
NCT ID NCT02164253
Summary
This small pilot study tested whether a drug called deferiprone, which removes excess iron from the body, is safe and might help slow the progression of ALS. The study involved 23 people with ALS and looked for changes in their symptoms and functional abilities over time. The main goal was to check if the treatment was safe and to see if reducing iron in the brain could help protect nerve cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALS (AMYOTROPHIC LATERAL SCLEROSIS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Roger Salengro, CHRU de Lille
Lille, 59000, France
Conditions
Explore the condition pages connected to this study.